Christopher M. Reese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christopher M. Reese has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Arash Etemadi
Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA
9 shared publications - Christian C. Abnet
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
9 shared publications - Neal D. Freedman
Division of Cancer Control and Population Sciences, National Cancer Institute , Rockville, MD
9 shared publications - Yuesong Wang
Centers for Disease Control and Prevention 5 Division of Laboratory Sciences, National Center for Environmental Health Atlanta, Georgia
9 shared publications - Andrea L. Gonzalez
Centers for Disease Control and Prevention 6 Battelle Memorial Institute Atlanta, Georgia
8 shared publications - Elizabeth I. Hamelin
Emergency Response Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
8 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Figure S1 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use among those who use opium by smoking. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Figure S1 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use among those who use opium by smoking. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Data from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Background:Opium consumption, a recognized carcinogen, is associated with lung cancer. However, the relative contributions of its potentially carcinogenic constituents to lung cancer risk remain unclear. Methods:We conducted a nested case–control study among opium users in the Golestan Cohort Study, including 53 incident lung cancer cases and 53 controls matched on age, sex, tobacco use, place of residence, and enrollment time. Urinary biomarkers of opioids, volatile organic compounds (VOC), polycyclic aromatic hydrocarbons (PAH), cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and creatinine were measured in baseline samples. Adjusted logistic regression analyses, as well as mediation analyses, were used to evaluate the associations between biomarker concentrations and lung cancer incidence. Results:We found statistically significant associations between 3- and 6-glucuronide of morphine, as well as metabolites of acrylonitrile/ethylene oxide (2-hydroxyethyl mercapturic acid) and propylene oxide (2-hydroxypropyl mercapturic acid), and lung cancer among opium users, especially those who smoked opium. Associations between VOC metabolites and lung cancer were independent of opioid biomarkers, and mediation analysis showed no evidence that VOCs mediate the effects of opioid biomarkers on lung cancer. No associations were observed for PAH biomarkers, cotinine and NNAL. Conclusions:Our findings provide biochemical evidence supporting the association between opium use and lung cancer, highlighting independent mechanisms related to both opioid and non-opioid components of opium, with varying effects by route of use. Impact:Opioids and chemical constituents produced during opium consumption must be considered in cancer risk assessment.See related In the Spotlight, p. 1801
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Background:Opium consumption, a recognized carcinogen, is associated with lung cancer. However, the relative contributions of its potentially carcinogenic constituents to lung cancer risk remain unclear. Methods:We conducted a nested case–control study among opium users in the Golestan Cohort Study, including 53 incident lung cancer cases and 53 controls matched on age, sex, tobacco use, place of residence, and enrollment time. Urinary biomarkers of opioids, volatile organic compounds (VOC), polycyclic aromatic hydrocarbons (PAH), cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and creatinine were measured in baseline samples. Adjusted logistic regression analyses, as well as mediation analyses, were used to evaluate the associations between biomarker concentrations and lung cancer incidence. Results:We found statistically significant associations between 3- and 6-glucuronide of morphine, as well as metabolites of acrylonitrile/ethylene oxide (2-hydroxyethyl mercapturic acid) and propylene oxide (2-hydroxypropyl mercapturic acid), and lung cancer among opium users, especially those who smoked opium. Associations between VOC metabolites and lung cancer were independent of opioid biomarkers, and mediation analysis showed no evidence that VOCs mediate the effects of opioid biomarkers on lung cancer. No associations were observed for PAH biomarkers, cotinine and NNAL. Conclusions:Our findings provide biochemical evidence supporting the association between opium use and lung cancer, highlighting independent mechanisms related to both opioid and non-opioid components of opium, with varying effects by route of use. Impact:Opioids and chemical constituents produced during opium consumption must be considered in cancer risk assessment.See related In the Spotlight, p. 1801
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Figure S2 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use among those who use opium by ingestion. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Figure S2 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use among those who use opium by ingestion. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Figure S3 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use in the total sample. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Figure S3 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use in the total sample. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Table S2 shows Associations between VOC and PAH biomarkers and lung cancer, stratified by routes of opium use
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Table S2 shows Associations between VOC and PAH biomarkers and lung cancer, stratified by routes of opium use
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Table S3 shows Coefficients from mediation analysis on the indirect effect of VOC metabolites mediating the associations between morphine glucuronides and lung cancer (third tertile compared to first tertile) among people who used opium by smoking
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Table S3 shows Coefficients from mediation analysis on the indirect effect of VOC metabolites mediating the associations between morphine glucuronides and lung cancer (third tertile compared to first tertile) among people who used opium by smoking
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Table S1 shows Biomarkers related to opium exposure and their coefficients of variation
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Supplementary Table S1 shows Biomarkers related to opium exposure and their coefficients of variation
- Open Access
- 24 July 2026
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 277, 114877
Urinary biomarkers of PAHs, VOCs, OPEs, and metal(loid)s in firefighters responding in the wildland urban interface (WUI)
- 24 July 2026
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 277, 114877
Open AccessUrinary biomarkers of PAHs, VOCs, OPEs, and metal(loid)s in firefighters responding in the wildland urban interface (WUI)
- Open Access
- 15 July 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (7) , 905
Volatile Organic Compound Metabolites Are Found in the Urine of Breastfed Infants Whose Mothers Use Cannabis: The Lactation and Cannabis (LAC) Study
Cannabis use among breastfeeding women is increasing. While studies have shown that cannabinoids transfer into human milk, whether breastfed infants of mothers who use cannabis are exposed to volatile organic compounds (VOCs) is not known. Here, we characterized VOC metabolite concentrations in urine produced by exclusively breastfed infants whose mothers used cannabis. Relationships between infant urinary VOC metabolite concentrations and milk delta-9-tetrahydrocannabinol (∆9-THC) concentrations and cannabis use modality (smoking/vaping) were documented. Twenty mother–infant dyads (9-THC. Results indicate detectable levels of 24 VOC metabolites in infant urine. Non-baseline infant urine had greater concentrations of 15 VOC metabolites than matched baseline samples (p < 0.05). Urinary 2CyEMA (acrylonitrile metabolite) and 2CaEMA (acrylamide metabolite) concentrations were positively correlated with ∆9-THC concentrations in milk. Urinary 2CyEMA concentrations were higher in infants whose mothers primarily smoked (including those who smoked and vaped) compared to those who exclusively vaped (B = −0.637, SE = 0.317, p = 0.044). 2CaEMA concentrations were also greater in the urine produced by infants whose mothers reported any cannabis smoking versus only vaping on the study day (B = −4.06, SE = 1.42, p = 0.004). Results indicate that infants whose mothers use cannabis have measurable VOC exposure. Further research is needed to assess the potential health implications, if any.
- 15 July 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (7) , 905
Open AccessVolatile Organic Compound Metabolites Are Found in the Urine of Breastfed Infants Whose Mothers Use Cannabis: The Lactation and Cannabis (LAC) Study
Cannabis use among breastfeeding women is increasing. While studies have shown that cannabinoids transfer into human milk, whether breastfed infants of mothers who use cannabis are exposed to volatile organic compounds (VOCs) is not known. Here, we characterized VOC metabolite concentrations in urine produced by exclusively breastfed infants whose mothers used cannabis. Relationships between infant urinary VOC metabolite concentrations and milk delta-9-tetrahydrocannabinol (∆9-THC) concentrations and cannabis use modality (smoking/vaping) were documented. Twenty mother–infant dyads (9-THC. Results indicate detectable levels of 24 VOC metabolites in infant urine. Non-baseline infant urine had greater concentrations of 15 VOC metabolites than matched baseline samples (p < 0.05). Urinary 2CyEMA (acrylonitrile metabolite) and 2CaEMA (acrylamide metabolite) concentrations were positively correlated with ∆9-THC concentrations in milk. Urinary 2CyEMA concentrations were higher in infants whose mothers primarily smoked (including those who smoked and vaped) compared to those who exclusively vaped (B = −0.637, SE = 0.317, p = 0.044). 2CaEMA concentrations were also greater in the urine produced by infants whose mothers reported any cannabis smoking versus only vaping on the study day (B = −4.06, SE = 1.42, p = 0.004). Results indicate that infants whose mothers use cannabis have measurable VOC exposure. Further research is needed to assess the potential health implications, if any.
- 18 May 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (11) , 1880-1887
Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Background: Opium consumption, a recognized carcinogen, is associated with lung cancer. However, the relative contributions of its potentially carcinogenic constituents to lung cancer risk remain unclear. Methods: We conducted a nested case–control study among opium users in the Golestan Cohort Study, including 53 incident lung cancer cases and 53 controls matched on age, sex, tobacco use, place of residence, and enrollment time. Urinary biomarkers of opioids, volatile organic compounds (VOC), polycyclic aromatic hydrocarbons (PAH), cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and creatinine were measured in baseline samples. Adjusted logistic regression analyses, as well as mediation analyses, were used to evaluate the associations between biomarker concentrations and lung cancer incidence. Results: We found statistically significant associations between 3- and 6-glucuronide of morphine, as well as metabolites of acrylonitrile/ethylene oxide (2-hydroxyethyl mercapturic acid) and propylene oxide (2-hydroxypropyl mercapturic acid), and lung cancer among opium users, especially those who smoked opium. Associations between VOC metabolites and lung cancer were independent of opioid biomarkers, and mediation analysis showed no evidence that VOCs mediate the effects of opioid biomarkers on lung cancer. No associations were observed for PAH biomarkers, cotinine and NNAL. Conclusions: Our findings provide biochemical evidence supporting the association between opium use and lung cancer, highlighting independent mechanisms related to both opioid and non-opioid components of opium, with varying effects by route of use. Impact: Opioids and chemical constituents produced during opium consumption must be considered in cancer risk assessment. See related In the Spotlight, p. 1801
- 18 May 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (11) , 1880-1887
Biomarkers of Opioids, Volatile Organic Compounds, and Polycyclic Aromatic Hydrocarbons and Lung Cancer Incidence among Opium Users
Background: Opium consumption, a recognized carcinogen, is associated with lung cancer. However, the relative contributions of its potentially carcinogenic constituents to lung cancer risk remain unclear. Methods: We conducted a nested case–control study among opium users in the Golestan Cohort Study, including 53 incident lung cancer cases and 53 controls matched on age, sex, tobacco use, place of residence, and enrollment time. Urinary biomarkers of opioids, volatile organic compounds (VOC), polycyclic aromatic hydrocarbons (PAH), cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and creatinine were measured in baseline samples. Adjusted logistic regression analyses, as well as mediation analyses, were used to evaluate the associations between biomarker concentrations and lung cancer incidence. Results: We found statistically significant associations between 3- and 6-glucuronide of morphine, as well as metabolites of acrylonitrile/ethylene oxide (2-hydroxyethyl mercapturic acid) and propylene oxide (2-hydroxypropyl mercapturic acid), and lung cancer among opium users, especially those who smoked opium. Associations between VOC metabolites and lung cancer were independent of opioid biomarkers, and mediation analysis showed no evidence that VOCs mediate the effects of opioid biomarkers on lung cancer. No associations were observed for PAH biomarkers, cotinine and NNAL. Conclusions: Our findings provide biochemical evidence supporting the association between opium use and lung cancer, highlighting independent mechanisms related to both opioid and non-opioid components of opium, with varying effects by route of use. Impact: Opioids and chemical constituents produced during opium consumption must be considered in cancer risk assessment. See related In the Spotlight, p. 1801